Targeting the Immune system and Epigenetic Landscape of Urological Tumors
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the Immune system and Epigenetic Landscape of Urological Tumors
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 3, Pages 829
Publisher
MDPI AG
Online
2020-01-28
DOI
10.3390/ijms21030829
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer
- (2019) Sara Monteiro-Reis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Human Germ Cell Tumors are Developmental Cancers: Impact of Epigenetics on Pathobiology and Clinic
- (2019) João Lobo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression
- (2019) Irina Lerman et al. MOLECULAR CANCER RESEARCH
- Epigenetic treatment combinations to effectively target cisplatin‐resistant germ cell tumors‐past, present, and future considerations
- (2019) C. Oing et al. Andrology
- Regulation of Chemokines and Cytokines by Histone Deacetylases and an Update on Histone Decetylase Inhibitors in Human Diseases
- (2019) Himavanth Gatla et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancer
- (2019) Swathi Ramakrishnan et al. CELL DEATH AND DIFFERENTIATION
- Immune Infiltration in Renal Cell Carcinoma
- (2019) Shichao Zhang et al. CANCER SCIENCE
- Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells
- (2019) Yue-peng Cao et al. ACTA PHARMACOLOGICA SINICA
- Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy
- (2019) Debarati Banik et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- DNA-Methylation-Based Detection of Urological Cancer in Urine: Overview of Biomarkers and Considerations on Biomarker Design, Source of DNA, and Detection Technologies
- (2019) Louise Katrine Larsen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Complex Interplay between Metabolic Reprogramming and Epigenetic Alterations in Renal Cell Carcinoma
- (2019) Ana Lameirinhas et al. Genes
- Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma
- (2019) Pooja Ghatalia et al. Journal for ImmunoTherapy of Cancer
- The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression
- (2019) Wenjing Su et al. CANCER CELL
- Phase II study of avelumab in multiple relapsed/refractory germ cell cancer
- (2019) M. Mego et al. INVESTIGATIONAL NEW DRUGS
- Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression
- (2019) Cristina Segovia et al. NATURE MEDICINE
- Paederia foetida induces anticancer activity by modulating chromatin modification enzymes and altering pro-inflammatory cytokine gene expression in human prostate cancer cells
- (2019) Nibedita Pradhan et al. FOOD AND CHEMICAL TOXICOLOGY
- Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2019) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of cancer testis antigen (CT10, PRAME) and MHC I expression in high-grade urothelial carcinoma of the bladder
- (2019) Anjelica Hodgson et al. VIRCHOWS ARCHIV
- Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging
- (2019) Arnas Bakavicius et al. Clinical Epigenetics
- XIST-Promoter Demethylation as Tissue Biomarker for Testicular Germ Cell Tumors and Spermatogenesis Quality
- (2019) Lobo et al. Cancers
- Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors
- (2019) Violeta Bakardjieva-Mihaylova et al. Cancers
- Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction
- (2019) David Bidarra et al. Frontiers in Oncology
- Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma
- (2019) David J. Clark et al. CELL
- Liquid biopsy in germ cell tumors: biology and clinical management
- (2019) Michal Chovanec et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition
- (2019) Wendy Mao et al. Journal for ImmunoTherapy of Cancer
- Detailed Characterization of Immune Cell Infiltrate and Expression of Immune Checkpoint Molecules PD-L1/CTLA-4 and MMR Proteins in Testicular Germ Cell Tumors Disclose Novel Disease Biomarkers
- (2019) João Lobo et al. Cancers
- Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications
- (2019) Magdalene Joseph et al. Frontiers in Oncology
- The epigenetic and transcriptional landscape of neuroendocrine prostate cancer
- (2019) Alastair Davies et al. ENDOCRINE-RELATED CANCER
- PD-L1 Immunohistochemistry Assay Concordance in Urothelial Carcinoma of the Bladder and Hypopharyngeal Squamous Cell Carcinoma
- (2018) Anjelica Hodgson et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer
- (2018) Ciputra Adijaya Hartana et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Nivolumab for the treatment of urothelial cancers
- (2018) Min Yuen Teo et al. Expert Review of Anticancer Therapy
- Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists
- (2018) João Lobo et al. HUMAN PATHOLOGY
- Epigenetics in renal cell cancer: mechanisms and clinical applications
- (2018) Sophie C. Joosten et al. Nature Reviews Urology
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- High immunoexpression of Ki67, EZH2, and SMYD3 in diagnostic prostate biopsies independently predicts outcome in patients with prostate cancer
- (2018) João Lobo et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Molecular and cellular mechanisms of castration resistant prostate cancer (Review)
- (2018) Yiqiao Huang et al. Oncology Letters
- Integrated Molecular Characterization of Testicular Germ Cell Tumors
- (2018) Hui Shen et al. Cell Reports
- The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
- (2018) Christopher J. Ricketts et al. Cell Reports
- Urine cell-based DNA methylation classifier for monitoring bladder cancer
- (2018) Antoine G. van der Heijden et al. Clinical Epigenetics
- Immune checkpoint inhibitors in urothelial cancer: recent updates and future outlook
- (2018) Dharmesh Gopalakrishnan et al. Therapeutics and Clinical Risk Management
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer
- (2018) A. Gordon Robertson et al. CELL
- An Open-label Randomized Phase 2 study of Durvalumab Alone or in Combination with Tremelimumab in Patients with Advanced Germ Cell Tumors (APACHE): Results from the First Planned Interim Analysis
- (2018) Andrea Necchi et al. EUROPEAN UROLOGY
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Integrative Epigenetic and Gene Expression Analysis of Renal Tumor Progression to Metastasis
- (2018) Hye-Young Nam et al. MOLECULAR CANCER RESEARCH
- The Current and Evolving Landscape of First‐Line Treatments for Advanced Renal Cell Carcinoma
- (2018) Emiliano Calvo et al. ONCOLOGIST
- The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection
- (2018) Martin C. S. Wong et al. Scientific Reports
- Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients
- (2018) Emma Ahlén Bergman et al. Clinical Epigenetics
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- PD-L1 Antibody Comparison in Urothelial Carcinoma
- (2018) Maud Rijnders et al. EUROPEAN UROLOGY
- Synergistic Antitumor Effect on Bladder Cancer by Rational Combination of Programmed Cell Death 1 Blockade and CRISPR-Cas9-Mediated Long Non-Coding RNA Urothelial Carcinoma Associated 1 Knockout
- (2018) Shuai Zhen et al. HUMAN GENE THERAPY
- Evolving Systemic Treatment Landscape for Patients With Advanced Renal Cell Carcinoma
- (2018) Rana R. McKay et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetic Alterations in Bladder Cancer
- (2018) Sima P. Porten Current Urology Reports
- The Role of DNA/Histone Modifying Enzymes and Chromatin Remodeling Complexes in Testicular Germ Cell Tumors
- (2018) João Lobo et al. Cancers
- MSH2 Expression and Resistance to Cisplatin in Muscle-invasive Bladder Cancer: A Mix of Progress and Challenges
- (2018) Rui Henrique et al. EUROPEAN UROLOGY
- SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization
- (2017) Maria João Ferreira et al. Epigenetics
- Global Burden of Urologic Cancers, 1990–2013
- (2017) Geolani W. Dy et al. EUROPEAN UROLOGY
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
- (2017) Sebastien Antoni et al. EUROPEAN UROLOGY
- Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset
- (2017) Woonyoung Choi et al. EUROPEAN UROLOGY
- Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?
- (2017) Mahmoud A Ali et al. Immunotherapy
- Immunotherapy for Prostate Cancer: Where We Are Headed
- (2017) Giuseppe Schepisi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exploiting Epigenetic Alterations in Prostate Cancer
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Combination treatment with docetaxel and histone deacetylase inhibitors downregulates androgen receptor signaling in castration-resistant prostate cancer
- (2017) Sang Eun Park et al. INVESTIGATIONAL NEW DRUGS
- Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification
- (2017) Gottfrid Sjödahl et al. JOURNAL OF PATHOLOGY
- Dissecting major signaling pathways in prostate cancer development and progression: Mechanisms and novel therapeutic targets
- (2017) Senthilmurugan Ramalingam et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Epigenetics and immunotherapy: The current state of play
- (2017) Jennifer Dunn et al. MOLECULAR IMMUNOLOGY
- Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation
- (2017) Aristotle Bamias et al. ONCOLOGIST
- Decitabine, a DNA-demethylating agent, promotes differentiation via NOTCH1 signaling and alters immune-related pathways in muscle-invasive bladder cancer
- (2017) Swathi Ramakrishnan et al. Cell Death & Disease
- The epigenetics of testicular germ cell tumors: looking for novel disease biomarkers
- (2017) Ana Laura Costa et al. Epigenomics
- Prognostic role of programmed-death ligand 1 (PD-L1) expressing tumor infiltrating lymphocytes in testicular germ cell tumors
- (2017) Michal Chovanec et al. Oncotarget
- Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance
- (2017) Runhan Ren et al. Oncotarget
- Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer
- (2017) Alfonso Urbanucci et al. Cell Reports
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Twist1/Dnmt3a and miR186 establish a regulatory circuit that controls inflammation-associated prostate cancer progression
- (2017) X Zhao et al. Oncogenesis
- Prognostic and predictive biomarkers in prostate cancer: latest evidence and clinical implications
- (2017) Naoki Terada et al. Therapeutic Advances in Medical Oncology
- Bladder cancer
- (2017) Oner Sanli et al. Nature Reviews Disease Primers
- Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome
- (2016) Daniel M Berney et al. BRITISH JOURNAL OF CANCER
- DNA Methylation-Derived Neutrophil-to-Lymphocyte Ratio: An Epigenetic Tool to Explore Cancer Inflammation and Outcomes
- (2016) Devin C. Koestler et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Mutational Landscape and Sensitivity to Immune Checkpoint Blockers
- (2016) R. M. Chabanon et al. CLINICAL CANCER RESEARCH
- The evolving role of immunotherapy in prostate cancer
- (2016) Lisa M. Cordes et al. CURRENT OPINION IN ONCOLOGY
- Economic Burden of Bladder Cancer Across the European Union
- (2016) Jose Leal et al. EUROPEAN UROLOGY
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
- (2016) Holger Moch et al. EUROPEAN UROLOGY
- A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score
- (2016) Jonathan I. Epstein et al. EUROPEAN UROLOGY
- Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors
- (2016) J. Keith Killian et al. GENOME RESEARCH
- Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial
- (2016) David Cella et al. LANCET ONCOLOGY
- IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial
- (2016) Brian I Rini et al. LANCET ONCOLOGY
- Role of Epigenetic Modification and Immunomodulation in a Murine Prostate Cancer Model
- (2016) Jay E. Sulek et al. PROSTATE
- Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells
- (2016) S Gupta et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action
- (2016) I. Duran et al. Targeted Oncology
- Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection
- (2016) Oded Danziger et al. Oncotarget
- CXCL12 promoter methylation and PD-L1 expression as prognostic biomarkers in prostate cancer patients
- (2016) Diane Goltz et al. Oncotarget
- Inducible expression of cancer-testis antigens in human prostate cancer
- (2016) Erika Heninger et al. Oncotarget
- Inhibition of long non-coding RNA UCA1 by CRISPR/Cas9 attenuated malignant phenotypes of bladder cancer
- (2016) Shuai Zhen et al. Oncotarget
- Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells
- (2016) Sofia R. Gameiro et al. Oncotarget
- DNA Methylation-Mediated Downregulation of DEFB1 in Prostate Cancer Cells
- (2016) Jaehyouk Lee et al. PLoS One
- Prognostic value of programmed-death-1 receptor (PD-1) and its ligand 1 (PD-L1) in testicular germ cell tumors
- (2015) Z. Cierna et al. ANNALS OF ONCOLOGY
- Frequent PD-L1 expression in testicular germ cell tumors
- (2015) C D Fankhauser et al. BRITISH JOURNAL OF CANCER
- EHMT2 inhibitor BIX-01294 induces apoptosis through PMAIP1-USP9X-MCL1 axis in human bladder cancer cells
- (2015) Jing Cui et al. Cancer Cell International
- The Molecular Taxonomy of Primary Prostate Cancer
- (2015) Adam Abeshouse et al. CELL
- Molecular pathways in renal cell carcinoma
- (2015) Daniel Su et al. CURRENT OPINION IN ONCOLOGY
- Understanding the Mechanisms of Androgen Deprivation Resistance in Prostate Cancer at the Molecular Level
- (2015) Theodoros Karantanos et al. EUROPEAN UROLOGY
- Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions
- (2015) Xiao X Wei et al. Expert Review of Vaccines
- Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma
- (2015) Weisi Liu et al. MEDICINE
- G9a Inhibition Induces Autophagic Cell Death via AMPK/mTOR Pathway in Bladder Transitional Cell Carcinoma
- (2015) Feng Li et al. PLoS One
- Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
- (2015) Roberto Iacovelli et al. Targeted Oncology
- Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis
- (2015) Qing Zhang et al. Oncotarget
- Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation
- (2015) Xu Chen et al. Scientific Reports
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Recombinant bacillus Calmette-Guérin in urothelial bladder cancer immunotherapy: current strategies
- (2014) Yonghua Wang et al. Expert Review of Anticancer Therapy
- Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
- (2014) Eugene D Kwon et al. LANCET ONCOLOGY
- Furtherin vitroevaluation of cytotoxicity of the marine natural product derivative 4′-leucine-avarone
- (2014) Boris Pejin et al. NATURAL PRODUCT RESEARCH
- An insight into the cytotoxic activity of phytol atin vitroconditions
- (2014) Boris Pejin et al. NATURAL PRODUCT RESEARCH
- An oncofetal and developmental perspective on testicular germ cell cancer
- (2014) Martin A. Rijlaarsdam et al. SEMINARS IN CANCER BIOLOGY
- Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells
- (2014) Akinori Sato et al. BMC Urology
- High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014
- (2014) Janice P Dutcher et al. Journal for ImmunoTherapy of Cancer
- Prostate Cancer Molecular Detection in Plasma Samples by Glutathione S-Transferase P1 (GSTP1) Methylation Analysis
- (2013) Raluca Dumache et al. Clinical Laboratory
- New and Highly Potent Antitumor Natural Products from Marine-Derived Fungi: Covering the Period from 2003 to 2012
- (2013) Boris Pejin et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Role of epigenetics in the etiology of germ cell cancer
- (2013) Yvonne G. Van Der Zwan et al. INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Cancer testis antigen expression in testicular germ cell tumorigenesis
- (2013) Peter K Bode et al. MODERN PATHOLOGY
- Radiosensitisation of bladder cancer cells by panobinostat is modulated by Ku80 expression
- (2013) Blaz Groselj et al. RADIOTHERAPY AND ONCOLOGY
- Acetylation of histone H3 prevents resistance development caused by chronic mTOR inhibition in renal cell carcinoma cells
- (2012) Eva Juengel et al. CANCER LETTERS
- Polyamine-modulated Factor-1 Methylation Predicts Bacillus Calmette-Guérin Response in Patients with High-grade Non–muscle-invasive Bladder Carcinoma
- (2012) Miguel Alvarez-Múgica et al. EUROPEAN UROLOGY
- Molecular mechanisms of cisplatin resistance in bladder cancer
- (2012) Ross M Drayton et al. Expert Review of Anticancer Therapy
- Class I Histone Deacetylase Inhibitor Entinostat Suppresses Regulatory T Cells and Enhances Immunotherapies in Renal and Prostate Cancer Models
- (2012) Li Shen et al. PLoS One
- Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion
- (2012) Lukasz Hudak et al. PROSTATE
- Valproic acid decreases urothelial cancer cell proliferation and induces thrombospondin-1 expression
- (2012) Timothy K Byler et al. BMC Urology
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Evaluation of the Methylation Status of Tumour Suppressor Genes for Predicting Bacillus Calmette-Guérin Response in Patients With T1G3 High-Risk Bladder Tumours
- (2011) Miriam Agundez et al. EUROPEAN UROLOGY
- The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expression
- (2011) Daniel Nettersheim et al. GENES CHROMOSOMES & CANCER
- Potentiation of Mitomycin C Tumoricidal Activity for Transitional Cell Carcinoma by Histone Deacetylase Inhibitors In Vitro
- (2011) Abdalla Ali Deb et al. JOURNAL OF UROLOGY
- The Histone Deacetylase Inhibitor Trichostatin A Synergistically Resensitizes a Cisplatin Resistant Human Bladder Cancer Cell Line
- (2011) Cheol Yong Yoon et al. JOURNAL OF UROLOGY
- Signaling pathways in renal cell carcinoma
- (2010) Gowrishankar Banumathy et al. CANCER BIOLOGY & THERAPY
- Epigenetic Mechanisms of Promigratory Chemokine CXCL14 Regulation in Human Prostate Cancer Cells
- (2010) Eun Young Song et al. CANCER RESEARCH
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
- (2010) Gillian L. Dalgliesh et al. NATURE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alterations of the gene expression profile in renal cell carcinoma after treatment with the histone deacetylase-inhibitor valproic acid and interferon-alpha
- (2010) E. Juengel et al. WORLD JOURNAL OF UROLOGY
- Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration
- (2009) Vitaly Margulis et al. CANCER
- Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin Levels
- (2009) D. Mahalingam et al. CLINICAL CANCER RESEARCH
- Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models
- (2009) Claudio Festuccia et al. ENDOCRINE-RELATED CANCER
- Identification and Validation of the Methylated TWIST1 and NID2 Genes through Real-Time Methylation-Specific Polymerase Chain Reaction Assays for the Noninvasive Detection of Primary Bladder Cancer in Urine Samples
- (2009) Isabelle Renard et al. EUROPEAN UROLOGY
- The histone deacetylase inhibitor valproic acid alters growth properties of renal cell carcinomain vitroandin vivo
- (2008) Jon Jones et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now